Selected article for: "lung cancer and magnetic resonance imaging"

Author: Matsuo, Keisuke; Ishiguro, Takashi; Najama, Takatomo; Shimizu, Yoshihiko; Kobayashi, Yasuhito; Mutou, Makoto
Title: Nivolumab-induced Myocarditis Successfully Treated with Corticosteroid Therapy: A Case Report and Review of the Literature
  • Cord-id: y2n9z5sd
  • Document date: 2019_5_22
  • ID: y2n9z5sd
    Snippet: A 62-year-old man presented to our hospital for the further evaluation and treatment of his back pain, general fatigue, and dyspnea, which had developed 4 days after the 29th administration of nivolumab to treat his lung cancer. Based on his clinical history, elevated serum cardiac enzyme values, and cardiac magnetic resonance (CMR) imaging and myocardial biopsy findings, he was diagnosed with myocarditis induced by nivolumab. Corticosteroid therapy improved his condition, and CMR performed on h
    Document: A 62-year-old man presented to our hospital for the further evaluation and treatment of his back pain, general fatigue, and dyspnea, which had developed 4 days after the 29th administration of nivolumab to treat his lung cancer. Based on his clinical history, elevated serum cardiac enzyme values, and cardiac magnetic resonance (CMR) imaging and myocardial biopsy findings, he was diagnosed with myocarditis induced by nivolumab. Corticosteroid therapy improved his condition, and CMR performed on hospital day 11 also showed remarkable improvement. Although nivolumab-induced myocarditis is rare, cardiologists should consider it when encountering patients treated with such a drug for malignant disease.

    Search related documents:
    Co phrase search for related documents
    • acute myocardial infarction and lymph node: 1
    • acute phase and adenocarcinoma diagnosis: 1
    • acute phase and admission week: 1, 2
    • acute phase and lung adenocarcinoma: 1
    • acute phase and lung cancer: 1, 2, 3, 4, 5, 6, 7
    • acute phase and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute phase and lymph node: 1, 2, 3, 4, 5
    • adenocarcinoma diagnosis and administration year: 1
    • adenocarcinoma diagnosis and admission week: 1
    • adenocarcinoma diagnosis and lung adenocarcinoma: 1, 2, 3, 4
    • adenocarcinoma diagnosis and lung cancer: 1, 2, 3, 4, 5
    • adenocarcinoma diagnosis and lung disease: 1
    • adenocarcinoma diagnosis and lymph node: 1, 2, 3, 4
    • administration year and lung cancer: 1, 2, 3
    • administration year and lung disease: 1
    • administration year develop and lung cancer: 1
    • admission week and lung disease: 1
    • admission week and lymph node: 1
    • admission week and lymphocyte antigen: 1